Sullivan John F 4
4 · TransMedics Group, Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Sullivan John F
VP of Quality & Engineering
Transactions
- Sale
Common Stock
2021-04-07$37.46/sh−3,949$147,930→ 10,828 total - Exercise/Conversion
Common Stock
2021-04-07$16.14/sh+3,000$48,420→ 13,828 total - Exercise/Conversion
Common Stock
2021-04-07$2.21/sh+12,000$26,520→ 25,828 total - Sale
Common Stock
2021-04-07$35.86/sh−2,067$74,123→ 23,761 total - Sale
Common Stock
2021-04-07$36.77/sh−8,984$330,342→ 14,777 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-07−3,000→ 12,000 totalExercise: $16.14Exp: 2030-02-27→ Common Stock (3,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-07−12,000→ 12,437 totalExercise: $2.21Exp: 2027-06-22→ Common Stock (12,000 underlying)
Footnotes (6)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.20 to $35.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $36.20 to $37.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $37.20 to $37.75 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
- [F6]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017.